Stocks to watch today on February 9: Torrent Pharma, NMDC, Astrazeneca Pharma, Future Retail, Wipro, Tata Motors among others are the top stocks to watch out for in Tuesday's trading session

Stock Market News Updates Today: Sensex hit a record high of 51,753 and the Nifty hit a record high of 51,753 in early trade today. Both benchmark indices have gained over 11% in seven straight sessions

Indoco Remedies share was trading higher than 5, 20, 50, 100 and 200-day moving averages. The stock has gained 10.77% in the last 3 days

India Stock Market Highlights Today: Maruti Suzuki, Hindalco, Tata Steel and GAIL India were the top gainers on Nifty rising up to 3.62%. SBI Life Insurance, Infosys, Bharti Airtel and Axis Bank were the top losers falling up to 1.79% on Nifty

India Stock Market Highlights Today: All Sensex stocks were trading in green led by ICICI Bank, Infosys, HCL Technologies, Axis Bank, HDFC Bank and Hindustan Unilever

Stocks to watch today on September 15: PVR, SAIL, Future Retail, HDFC, Voltas among others are the top stocks to watch out for in Tuesday's trading session.

On both the bourses, BSE and NSE, the pharma sector outperformed the broader market, which fell amid rising uncertainty among investors.  In the month of March, the healthcare sector on BSE has overall gained 473 points or 3.5%.

The USFDA's Office of Manufacturing Quality (OMQ) at the Centre for Drug Evaluation Research (CDER) evaluates compliance with cGMP for drugs based on inspection reports and evidence gathered by USFDA investigators

A number of Indian companies are facing action from the USFDA for failing manufacturing quality standards.

Leading Indian pharmaceutical companies are facing competition in the US from relatively smaller firms back home.

The US regulators increased scrutiny of Indian drug exporters is giving the pharmaceutical industry the jitters. Besides becoming more frequent, inspections are also more often unannounced. Adding to Indian drug makers anxiety is the nature and scope of the inspections.

Dependence on China has generated enough concerns for the Indian Drug Manufacturers' Association to call for anti-dumping duties on some bulk drugs and intermediates from the country.

Multinationals are closing in on Big Pharma, but there are enough mid-size stars as well.